AG
Artal Group’s Stoke Therapeutics STOK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-300,000
| Closed | -$4.05M | – | 125 |
|
2024
Q1 | $4.05M | Buy |
+300,000
| New | +$4.05M | 0.1% | 67 |
|
2023
Q3 | – | Sell |
-250,000
| Closed | -$2.66M | – | 115 |
|
2023
Q2 | $2.66M | Hold |
250,000
| – | – | 0.08% | 75 |
|
2023
Q1 | $2.08M | Hold |
250,000
| – | – | 0.12% | 80 |
|
2022
Q4 | $2.31M | Hold |
250,000
| – | – | 0.13% | 82 |
|
2022
Q3 | $3.21M | Hold |
250,000
| – | – | 0.14% | 72 |
|
2022
Q2 | $3.3M | Hold |
250,000
| – | – | 0.18% | 75 |
|
2022
Q1 | $5.26M | Hold |
250,000
| – | – | 0.22% | 73 |
|
2021
Q4 | $6M | Hold |
250,000
| – | – | 0.16% | 89 |
|
2021
Q3 | $6.36M | Hold |
250,000
| – | – | 0.14% | 98 |
|
2021
Q2 | $8.42M | Hold |
250,000
| – | – | 0.17% | 90 |
|
2021
Q1 | $9.71M | Hold |
250,000
| – | – | 0.17% | 89 |
|
2020
Q4 | $15.5M | Sell |
250,000
-20,750
| -8% | -$1.29M | 0.33% | 63 |
|
2020
Q3 | $9.07M | Sell |
270,750
-14,250
| -5% | -$477K | 0.22% | 68 |
|
2020
Q2 | $6.79M | Buy |
285,000
+35,000
| +14% | +$834K | 0.19% | 75 |
|
2020
Q1 | $5.73M | Buy |
+250,000
| New | +$5.73M | 0.24% | 61 |
|